Nothing Special   »   [go: up one dir, main page]

Ragelle et al., 2020 - Google Patents

Organ-on-a-chip technologies for advanced blood–retinal barrier models

Ragelle et al., 2020

View HTML
Document ID
4856643907253170861
Author
Ragelle H
Goncalves A
Kustermann S
Antonetti D
Jayagopal A
Publication year
Publication venue
Journal of ocular pharmacology and therapeutics

External Links

Snippet

The blood–retinal barrier (BRB) protects the retina by maintaining an adequate microenvironment for neuronal function. Alterations of the junctional complex of the BRB and consequent BRB breakdown in disease contribute to a loss of neuronal signaling and vision …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Similar Documents

Publication Publication Date Title
Ragelle et al. Organ-on-a-chip technologies for advanced blood–retinal barrier models
Gastfriend et al. Modeling the blood–brain barrier: beyond the endothelial cells
Hajal et al. Biology and models of the blood–brain barrier
Sivandzade et al. In-vitro blood–brain barrier modeling: A review of modern and fast-advancing technologies
Ingber Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?
Xie et al. h-FIBER: microfluidic topographical hollow fiber for studies of glomerular filtration barrier
Amirifar et al. Brain-on-a-chip: Recent advances in design and techniques for microfluidic models of the brain in health and disease
Edington et al. Interconnected microphysiological systems for quantitative biology and pharmacology studies
Duzagac et al. Microfluidic organoids-on-a-chip: Quantum leap in cancer research
Moya et al. In vitro perfused human capillary networks
Osaki et al. In vitro microfluidic models for neurodegenerative disorders
Zhou et al. Development of a functional glomerulus at the organ level on a chip to mimic hypertensive nephropathy
Tsai et al. Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment
Sudo et al. Transport-mediated angiogenesis in 3D epithelial coculture
Kim et al. Biological applications of microfluidic gradient devices
Francis et al. Recent advances in lung-on-a-chip models
Haderspeck et al. Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling
Pérez-López et al. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines
Hu et al. Vascularized tumor spheroid-on-a-chip model verifies synergistic vasoprotective and chemotherapeutic effects
Ebefors et al. Modeling the glomerular filtration barrier and intercellular crosstalk
Luque‐González et al. Human Microcirculation‐on‐Chip Models in Cancer Research: Key Integration of Lymphatic and Blood Vasculatures
Gao et al. Functional imaging of neuron–astrocyte interactions in a compartmentalized microfluidic device
Katt et al. In vitro models of the blood-brain barrier: building in physiological complexity
Bosworth et al. Modeling neurovascular disorders and therapeutic outcomes with human-induced pluripotent stem cells
Malik et al. Critical considerations for the design of multi-organ microphysiological systems (MPS)